KoreaTimes - Bio

Entertainment & Arts

Qatar 2022

SCMP
Asia

Entertainment & Arts

Qatar 2022

SCMP
Asia

Business

Bio

Thu, December 1, 2022 | 18:27

Seegene struggles to stay afloat as pandemic ebbs

Seegene struggles to stay afloat as pandemic ebbs

Seegene, which had enjoyed the soaring popularity of its COVID-19 PCR test kits, has been struggling to stay afloat as the pandemic has been ebbing, according to industry analysts, Monday. They said the time has passed for Seegene to enjoy high growth as the number of COVID-19 infections has gradually declined globally and much of the world is shifting to endemic mode.

Baek Byung-yeul | 2022-11-14 16:51

'Agility, digitalization are key edges of Samsung Biologics'

'Agility, digitalization are key edges of Samsung Biologics'

FRANKFURT - Samsung Biologics has been increasing its presence in the global contract development and manufacturing organization (CDMO) business, generating larger revenues than market expectations this year. Such growth was possible thanks to its agile response to improve production capacity and achieving a digital transformation, according to its executives, Tuesday.

Baek Byung-yeul | 2022-11-07 14:11

Yuyu Pharma aims to grow bigger with dry eye, hair loss drugs

Yuyu Pharma aims to grow bigger with dry eye, hair loss drugs

FRANKFURT - Robert Yu, president and CEO of Yuyu Pharma, said Wednesday that his mission is to make the company comparable to prominent biopharmaceutical companies in the world. To that end, he said the Korean company is actively diversifying its portfolio by developing new drugs such as a dry eye treatment as well as hair loss medication.

Baek Byung-yeul | 2022-11-06 11:51

Contract manufacturing emerges as new opportunity for Korean bio firms

Contract manufacturing emerges as new opportunity for Korean bio firms

FRANKFURT - The CPHI exhibition has become a place for finding new growth engines for Yungjin Pharm, Daewon Pharmaceutical, Kyongbo Pharm and other small Korean bio companies as they actively try to attract new clients for their contract manufacturing organization (CMO) business, according to the companies, Wednesday.

Baek Byung-yeul | 2022-11-03 16:09

New CEO vows to make SK pharmteco leading CDMO player

New CEO vows to make SK pharmteco leading CDMO player

FRANKFURT - Joerg Ahlgrimm, the new CEO of SK pharmteco, vowed Tuesday that his goal as a chief executive is to make the SK Group's contract development and manufacturing organization (CDMO) company one of the best players in the global cell and gene therapy (CGT) CDMO business. “We have technological leadership in the CDMO field and my goal is to create a significant competi...

Baek Byung-yeul | 2022-11-02 16:45

Samsung Biologics highlights essentials for global pharma-CDMO partnerships

Samsung Biologics highlights essentials for global pharma-CDMO partnerships

FRANKFURT - Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO) company that develops and produces drugs for its clients, said demand for biomedicine will exceed supply from 2026, adding that finding the best partner to outsource production is becoming more important for global pharmaceutical companies, according to its executive, Tue...

Baek Byung-yeul | 2022-11-01 19:05

Celltrion seeks new partnerships at CPhI bio exhibition

Celltrion seeks new partnerships at CPhI bio exhibition

FRANKFURT - Celltrion, a Korea-based biopharmaceutical company, is seeking to secure new partnerships at the CPhI bio pharmaceutical exhibition by opening an independent booth, the company said Tuesday. The exhibition is held every year touring major European cities. This year's event is in Frankfurt, Germany, for three days through Thursday, providing opportunities for medic...

Baek Byung-yeul | 2022-11-01 16:35

Samsung Biologics seeks to expand partnerships at CPhI

Samsung Biologics seeks to expand partnerships at CPhI

FRANKFURT - Samsung Biologics and other biotechnology companies in Korea will showcase their technologies and seek more business opportunities with global buyers at this year's CPhI bio pharmaceutical exhibition, according to the companies, Monday. The CPhI is an annual exhibition in the bio pharmaceutical industry held in Europe. This year's event will be held for three days...

Baek Byung-yeul | 2022-10-31 15:36

HLB Science to showcase sepsis treatment at BIO-Europe

HLB Science to showcase sepsis treatment at BIO-Europe

HLB Science, an affiliate of HLB Group, said Friday that it will showcase its sepsis treatment to medical experts and buyers at the BIO-Europe conference, which will be held virtually from Nov. 2 to 4. BIO-Europe is one of the largest pharmaceutical conferences in the biotechnology industry where around 2,000 companies from over 60 countries participate every year to discuss ...

Baek Byung-yeul | 2022-10-28 14:50

SK Bioscience aims to address vaccine inequality through global partnership

SK Bioscience aims to address vaccine inequality through global partnership

SK Bioscience, which developed Korea's first COVID-19 vaccine, SKYCovione, said Thursday that the biotech company aims to address the issue of vaccine inequality by intensifying collaboration with international organizations so that people living in low-income countries will be easily able to prevent life-threatening diseases. Rich, developed countries were the first to get a...

Baek Byung-yeul | 2022-10-20 16:43

1 2 3 4 5 6 7

Top 10 Stories

1	PHOTOSWorld Cup 2022 England vs Wales

2	Unionized Seoul Metro workers go on strike calling for safety

3	INTERVIEW34-year-old permaculture farmer runs zero-waste shop in Gangneung

4	Truckers' strike triggers fuel shortage

5	Are foreign investors returning to KOSPI?

6	Busan unveils roadmap for becoming English-friendly city to host Expo 2030

7	Fantasy of being 'Reborn Rich' amid harsh struggle of reality

8	S. Korea, US to co-host 2nd Summit for Democracy

9	Korean Air introduces A321neo equipped with Prestige class

10	Saudi minister visits Naver headquarters

DARKROOM